Company profile

Onera B.V.

Onera B.V. has 1 AI-enabled medical device on the FDA list. The first decision was on March 8, 2026 and the most recent on March 8, 2026 (Onera SleepMap (SLEEPMAP)). Its most common review panel is Neurology (1 device).

1AI devices
2026First decision
2026Latest decision
1Specialties

Timeline

  1. Onera SleepMap (SLEEPMAP) · Neurology · OLZ